Letter by wells and eisenberg regarding article, "statins for the primary prevention of cardiovascular events in women with elevated high-sensitivity C-reactive protein or dyslipidemia: Results from the justification for the use of statins in prevention: An intervention trial evaluating rosuvastatin (JUPITER) and meta-analysis of women from primary prevention trials" Letter uri icon

Overview

MeSH Major

  • C-Reactive Protein
  • Cardiovascular Diseases
  • Clinical Trials as Topic
  • Dyslipidemias
  • Fluorobenzenes
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Pyrimidines
  • Sulfonamides

publication date

  • December 7, 2010

Research

keywords

  • Letter

Identity

Digital Object Identifier (DOI)

  • 10.1161/CIRCULATIONAHA.110.953216

PubMed ID

  • 21135368

Additional Document Info

start page

  • e575; author reply e577

volume

  • 122

number

  • 23